黑料官网

header-logo
GettyImages-650160957-hero
Neurology
AmyHeffelfinger_Academic Profile

Amy K. Heffelfinger, PhD, MPE

Professor of Neurology, Neurosurgery and Pediatrics; Chief, Pediatric Neuropsychology

Locations

  • Neurology

Education

PhD, Washington University, St. Louis, MO, 1997
Masters in Psychiatric Epidemiology, Washington University School of Medicine, St. Louis, MO, 1999

Biography

Specialty

Neuropsychology

Subspecialties

Pediatric Neuropsychology
Infant and Preschool Children

Training

Internship, Pediatric Psychology and Child Neurology, University of Minnesota, Minneapolis, 1996-1997

Fellowship, Washington University Medical Center, St. Louis, MO, 1997-2000

Research Experience

  • Attention
  • Brain Neoplasms
  • Child, Preschool
  • Cognition
  • Diabetes Mellitus, Type 1
  • Genetic Diseases, Inborn
  • Mental Disorders
  • Nervous System Diseases
  • Neuropsychological Tests
  • Spina Bifida Cystica

Leadership Positions

  • Vice Chair, Faculty Development

Research Interests

Dr. Heffelfinger specializes in the evaluation and treatment of preschool and school-age children with neurological, behavioral, and developmental disorders in the Neuropsychology Clinic. Specialty evaluations are also provided through the Preschool and Infant Neuropsychological Testing (P.I.N.T.) Clinic and the Autism Clinic.

Dr. Heffelfinger's current research involves the study of early development of neuropsychological function, with a focus on attention and executive functioning. Her work also investigates cognitive outcomes of adolescents with spina bifida, brain tumor, and genetic disorders. She presents her research at national conventions and publishes in peer review journals.

Publications

  • (Zabel TA, Bernat DJ, Costello R, Bordes Edgar V, Heffelfinger AK, Jordan LL, Koop JI, Leiser K, MacDonald B, Stanford L, Stephan C, Thibadeau J, Wilson C, Queally JT.) Clin Neuropsychol. 2025 Oct 31:1-21 PMID: 41173466 SCOPUS ID: 2-s2.0-105021529949 11/01/2025

  • (Janecek JK, Loman MM, Heffelfinger A.) Clin Neuropsychol. 2025 Jul 23:1-29 PMID: 40698940 SCOPUS ID: 2-s2.0-105011694109 07/23/2025

  • (Stringer AY, Fuchs K, Bordes Edgar V, Bristow T, Correia S, Penna S, Reyes A, Whiteside DM, Block C, Bodin D, Butt S, Calamia M, Didehbani N, Dodzik P, Dotson VM, Fernandes M, Freece K, Fuller R, Getz G, Harder L, Irani F, Janzen L, Johnstone B, Kaseda E, Kramer M, Kubu C, Lafosse J, Lee-DaRocha J, MacDonald B, Strutt AM, Madore M, McBride W, Medina LD, Mucci G, Nayar K, Paltzer J, Ray C, Ready R, Schmitt TR, Rush B, Singh S, Sperling S, Stanford L, Stiers W, Stricker N, Thornton A, Van Patten R, Vandermorris S, Verroulx K, Wilson J, Wright I, Zartman A, Bilder R, Fujii D, Heffelfinger A, Parsons T, Puente AE, Rey-Casserly C, Roper B, Schmitter-Edgecombe M.) Clin Neuropsychol. 2025 Jul 02:1-42 PMID: 40604361 SCOPUS ID: 2-s2.0-105014105691 07/03/2025

  • (Miller LE, Glad DM, Luepke JC, Koop JI, Adams SJ, Carlton KA, Cohen SS, Heffelfinger AK.) Pediatr Neurol. 2025 Mar;164:122-128 PMID: 39892020 SCOPUS ID: 2-s2.0-85216481213 02/02/2025

  • (Jordan LL, Costello R, MacDonald B, Heffelfinger A, Jones EF, Zabel TA, Queally JT.) Top Spinal Cord Inj Rehabil. 2025;31(2):104-113 PMID: 40585011 PMCID: PMC12199565 SCOPUS ID: 2-s2.0-105010176922 07/01/2025

  • (Reyes A, Fuchs K, Penna S, Waldron EJ, Madore M, Heffelfinger A, Correia S, Bristow T, Whiteside DM, Stringer AY, Bordes Edgar V.) Clinical Neuropsychologist. 2025 SCOPUS ID: 2-s2.0-105021250399 01/01/2025

  • (Janecek JK, Lang B, Butt S, Kenealy L, Heffelfinger A.) Clin Neuropsychol. 2024 Oct;38(7):1501-1523 PMID: 38378477 SCOPUS ID: 2-s2.0-85186187382 02/21/2024

  • (Carlton K, Adams S, Fischer E, Foy A, Heffelfinger A, Jozwik J, Kim I, Koop J, Miller L, Stibb S, Cohen S.) Am J Perinatol. 2024 May;41(S 01):e1570-e1574 PMID: 36918156 PMCID: PMC11404723 SCOPUS ID: 2-s2.0-85161080974 03/15/2023

  • (Heffelfinger AK, Kaseda ET, Holliday DD, Miller LE, Koop JI.) J Clin Exp Neuropsychol. 2023 Nov;45(9):890-904 PMID: 38391129 SCOPUS ID: 2-s2.0-85186432893 02/23/2024

  • (Shapiro DN, Anderson C, Gragert MN, Johnson A, Heffelfinger A.) Clin Neuropsychol. 2023 May;37(4):821-840 PMID: 36369839 SCOPUS ID: 2-s2.0-85142136515 11/13/2022

  • (Karst, J. S., Miller, M., Heffelfinger, A. K., Newby, R. F., & Scott, J. P.) . 10/05/2022

  • (Meghan Miller, Rachel Landsman, J. Paul Scott & Amy K. Heffelfinger.) . Meghan Miller, Rachel Landsman, J. Paul Scott & Amy K. Heffelfinger (2022) Fostering equity in education and academic outcomes in children with sickle cell disease, The Clinical Neuropsychologist, 36:2, 245-263, DOI: 10.1080/13854046.2021.1945147 10/05/2022

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.